Bethesda, Md. – PDA/FDA's Joint Regulatory Conference recently held in Washington, D.C. has been an overwhelming success with over 800 regulators and scientists attending and discussing current and upcoming regulatory trends and quality requirements.
“We are very pleased to be the facilitator for the industry and the large attendance shows that the industry appreciates PDA's efforts,” states Richard Johnson, PDA President. "The PDA/FDA Joint Regulatory Conference is a network and discussion platform very much required by industry and regulators and we have seen both working close together to achieve the product quality needs for our joint client - the patient.”
The 2010 PDA/FDA Joint Regulatory Conference has been the 19th with a history of exceptional content and topics. “It is always a pleasure to be part of the PDA/FDA Joint Regulatory Conference, as it represents the best venue for networking, learning and discussions with peers and regulators,” says Maik Jornitz, PDA's Board of Directors Chair. “No other conference lets industry and regulators partner this close together. Learning being the prime objective, it has been always achieved without a doubt.”
Next years 2011 PDA/FDA Joint Regulatory Conference will be held September 19-23, 2011 in Washington, D.C.
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide. www.pda.org